Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure.
Endocrine Division, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
J E
JE
Mulder
D000328:Adult; D015519:Bone Density / Q000187:drug effects / Q000528:radiation effects; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002648:Child; D016889:Endometrial Neoplasms / Q000139:chemically induced; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D010024:Osteoporosis / Q000517:prevention & control; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced / Q000188:drug therapy*; D018570:Risk Assessment; D017741:Survivors; D013733:Testicular Diseases / Q000139:chemically induced / Q000188:drug therapy*; D013739:Testosterone / Q000627:therapeutic use
D013739:Testosterone